On August 4th the Wall Street Journal carried a breathless tale of how a handful of obscure oilfield suppliers were striking immense riches in the sand dunes of Wisconsin. Owing to the “shale revolution”, the stock price of an outfit that had originated in the stagnating business of supplying sand traps to golf courses, and which had been at death’s door as […]
Chapter 4: The Explosive Bubbles of the Early 2000s1. The Internet BubbleMost bubbles have been associated with some new technology (as in the tronics and biotech booms) or with some new business opportunity (as when the opening of profitable new trade opportunities spawned the South Sea Bubble). The Internet was associated with both: it represented a new technology, and it […]
It was generally a good year for biotechnology stocks, but the sector remains a risky one. Below are 20 biotechnology companies that lost more than 70% of their value in 2014. (Click here for a list of the best performers.)There aren’t many lessons here. Tolstoy said that happy families are all alike, and but every unhappy family is unhappy in […]
Bloomberg TelevisionTom LeeSee AlsoThe Most Hilarious Chart Of 2014This Is The Best Illustration Of History’s Bull And Bear Markets We’ve Seen YetThis Oil Map Answers The First Question Everyone Asks When Turmoil Hits The Middle EastAfter 2013’s 31% gain in the S&P 500, almost no one expected 2014 to see double-digit gains in the US stock market, especially considering the […]
© Carlo Allegri/Reuters A trader works on the floor of the New York Stock Exchange on the last day of trading before Christmas in the Manhattan borough of New York, December 24, 2014.U.S. stocks fluctuated, with the Standard & Poor’s 500 Index (SPX) poised for a third straight yearly gain as equity gauges climbed past multiple milestones last week.Gilead […]
Few industries offer the promise and pitfalls of biotechnology. Clinical wins and losses can lead to extraordinary stock gains or falls that make the sector best suited for only the most risk-tolerant investor. However, for investors willing to take on that risk, our Motley Fool contributors believe these three biotech stocks could offer significant opportunities in the coming year.Brian Orelli […]
Source: Celgene Corp.The volatility that comes with investing in biotech stocks can test the patience of even the most risk-tolerant investor. Many investors may be better served focusing on companies with proven track records of success rather than concentrating on emerging biotech stocks that are more promise than profit. Fortunately, investing in proven performers doesn’t have to mean sacrificing growth! […]
FundstratTom Lee.See AlsoRBC’s Jon Golub Comes Out With A Bullish 2015 PredictionMORGAN STANLEY: ‘It Ain’t A Bubble Yet’BARCLAYS: Stocks Are Going Nowhere Next Year”Be contrarian,” Tom Lee says. “Investors are expecting 2015 to be a low-return year and are focusing on deflation and Fed tightening.”Lee, the former chief US equity strategist for JPMorgan and current head of Fundstrat Global Advisors, […]
To say that biotech stocks have performed well as a group over the last two years is an understatement; they have absolutely crushed the broader markets. For example, the iShares Nasdaq Biotech Index has more than tripled the performance of the S&P 500 , and more than doubled the NASDAQ Composite , since 2012.This sustained move upward, though, has repeatedly […]
Source: MercK & Co.,Just when it looked as though the stock market couldn’t possibly finish the year higher, after its swoon in October, it proved the naysayers wrong. As of this writing, the S&P 500 has risen by 11% for the year, a tad bit higher than the stock markets’ historic annual return.But if you think that’s a solid return, […]
